Stay updated on Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a 'Locations' section with Georgia as a listed study location, and the previous 'Georgia Locations' entry was removed; the 'HHS Vulnerability Disclosure' footer link was also removed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe Publications section text was updated to indicate publications are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page no longer displays the general government funding/operating status notice (including references to cc.nih.gov and opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedThe study page content appears unchanged in core details. No critical study information has been altered.SummaryDifference0.4%

- Check73 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference3%

- Check80 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.